Innovation

30 posts

Cancer Treatment – Access is the Real Obstacle – Asrar Qureshi’s Blog Post #1312

Asrar Qureshi’s blog discusses the MARS mission, emphasizing that improving access to existing cancer care technologies may be more crucial than new discoveries. Key issues include disparities in patient access, the need for decentralized clinical trials, and the importance of early detection and international collaboration to address the global cancer crisis effectively.
Share
View Post
  • 6 min

New Drug Discovery – Putting Patients First – Asrar Qureshi’s Blog Post #1304

Asrar Qureshi’s Blog Post #1304 highlights Astellas Pharma’s innovative approach to drug development, emphasizing patient-centric decision-making. The company shifts from traditional therapeutic areas to a model based on biology, modality, and disease. Astellas champions learning from failures, cross-functional teams, and harnessing automation to enhance patient outcomes and operational efficiency.
Share
View Post
  • 6 min

Funding Cuts Threaten Progress Against HIV, Hepatitis and STIs – Asrar Qureshi’s Blog Post #1298

The WHO warns that declining international funding threatens progress against HIV, hepatitis, and STIs. After decades of advancements, reduced financial support risks reversing achievements in prevention, testing, and treatment. Sustained investment, community leadership, and integrated healthcare are crucial to maintaining progress and addressing global health equity.
Share
View Post
  • 6 min

The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293

Asrar Qureshi’s blog discusses the exit of multinational pharmaceutical companies from Pakistan and the country’s potential to attract them back. Highlighting necessary reforms in pricing, regulation, and clinical research, it stresses a long-term vision for the pharmaceutical sector as vital for economic growth and public health security. Collaboration between domestic and multinational firms is essential for success.
Share
View Post
  • 6 min

WHO Prequalifies First Ever Malaria Treatment for Newborns and Infants – Asrar Qureshi’s Blog Post #1259

The WHO’s approval of Coartem Baby marks a historic achievement in malaria treatment for newborns and young infants, addressing a critical gap in healthcare. Developed by Novartis and Medicines for Malaria Venture, this innovative drug provides a safer, accurately dosed option, highlighting the importance of inclusive pharmaceutical innovation and collaborative efforts in global health.
Share
View Post
  • 6 min

Balancing Execution and Innovation in a Fast-Changing World – Asrar Qureshi’s Blog Post 1156

This blog post addresses senior managers in the pharmaceutical industry, emphasizing the critical balance between execution and innovation. It highlights the risks of focusing solely on one, urging leaders to foster environments that nurture both disciplines. The dual operating system model by John P. Kotter is presented as a solution for sustainable growth amidst constant change.
Share
View Post
  • 6 min

Technical Expertise vs Customer Experience – Asrar Qureshi’s Blog Post 1150

Asrar Qureshi’s blog post discusses the importance of balancing technical innovation with customer experience in the pharmaceutical industry. Historical examples like Exubera and Vioxx illustrate how neglecting user needs can lead to commercial failure. The future of pharma hinges on prioritizing usability, safety, trust, and accessibility to ensure successful adoption.
Share
View Post
  • 5 min

Putting Patient Care First – Asrar Qureshi’s Blog Post #1120

In healthcare, patient care must be prioritized above profit-driven motives, as emphasized by Drew Ungerman from McKinsey. Effective systems should focus on improving patient experiences, shifting from “sick care” to “health care.” Innovations should enhance access and reduce disparities, ensuring care is human-centered, dignified, and empathetic.
Share
View Post
  • 6 min

Five AI Trends to Watch in 2025 (and Beyond) – Asrar Qureshi’s Blog Post #1061

Asrar Qureshi’s blog outlines five significant AI trends expected by 2025. These include the democratization of coding through AI tools, the creation of high-quality AI-generated films, the rise of autonomous AI agents, improving affordability and performance of AI technologies, and an ongoing AI development surge amidst limited government regulation.
Share